Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
优化微管稳定三唑并嘧啶作为阿尔茨海默病和相关 tau蛋白病的治疗方法
基本信息
- 批准号:10553899
- 负责人:
- 金额:$ 31.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Statement of Work
Specific activities overseen by the Brunden laboratory include: 1) testing of prodrugs in established
HEK293 and neuron microtubule stabilization assays; 2) intravenous and oral pharmacokinetic testing of
prodrugs to determine the rate of conversion of prodrugs to the desired active compound; 3) assessment of
preferred prodrugs for pharmacodynamic effect in wild-type mice to establish the minimum effective
dose and duration of compound effect; and 4) determination of preferred prodrug acute maximum
tolerated dose and the no adverse effect dose after 3 weeks of dosing.
工作说明书
布伦登实验室监督的具体活动包括:1)在已建立的
HEK293和神经元微管稳定化试验;2)静脉和口服药代动力学试验
前药物,以确定前药物向所需活性化合物的转化率;3)评估
优选前体药物在野生型小鼠体内的药效学最低效价的确定
复合作用的剂量和持续时间;4)首选前体药物急性最大限度的测定
给药3周后的耐受量和无不良反应剂量。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Microtubule-Stabilizing 1,2,4-Triazolo[1,5-a]pyrimidines as Candidate Therapeutics for Neurodegenerative Disease: Matched Molecular Pair Analyses and Computational Studies Reveal New Structure-Activity Insights.
- DOI:10.1021/acs.jmedchem.2c01411
- 发表时间:2023-01-12
- 期刊:
- 影响因子:7.3
- 作者:Alle, Thibault;Varricchio, Carmine;Yao, Yuemang;Lucero, Bobby;Nzou, Goodwell;Demuro, Stefania;Muench, Megan;Vuong, Khoa D.;Oukoloff, Killian;Cornec, Anne-Sophie;Francisco, Karol R.;Caffrey, Conor R.;Lee, Virginia M. -Y.;Smith III, Amos B.;Brancale, Andrea;Brunden, Kurt R.;Ballatore, Carlo
- 通讯作者:Ballatore, Carlo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KURT R. BRUNDEN其他文献
KURT R. BRUNDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KURT R. BRUNDEN', 18)}}的其他基金
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
优化微管稳定三唑并嘧啶作为阿尔茨海默病和相关 tau蛋白病的治疗方法
- 批准号:
10364719 - 财政年份:2019
- 资助金额:
$ 31.15万 - 项目类别:
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
优化微管稳定三唑并嘧啶作为阿尔茨海默病和相关 tau蛋白病的治疗方法
- 批准号:
10398425 - 财政年份:2019
- 资助金额:
$ 31.15万 - 项目类别:
Orally-absorbed, small molecule microtubule-stabilizers for tauopathy treatment
用于治疗 tau 蛋白病的口服吸收小分子微管稳定剂
- 批准号:
8478876 - 财政年份:2013
- 资助金额:
$ 31.15万 - 项目类别:
Orally-absorbed, small molecule microtubule-stabilizers for tauopathy treatment
用于治疗 tau 蛋白病的口服吸收小分子微管稳定剂
- 批准号:
8670685 - 财政年份:2013
- 资助金额:
$ 31.15万 - 项目类别:
Brain-Penetrant Thromboxane Receptor Antagonists for Alzheimer's Disease Therapy
用于治疗阿尔茨海默病的脑渗透性血栓烷受体拮抗剂
- 批准号:
8318128 - 财政年份:2010
- 资助金额:
$ 31.15万 - 项目类别:
Brain-Penetrant Thromboxane Receptor Antagonists for Alzheimer's Disease Therapy
用于治疗阿尔茨海默病的脑渗透性血栓烷受体拮抗剂
- 批准号:
8522104 - 财政年份:2010
- 资助金额:
$ 31.15万 - 项目类别:
Brain-Penetrant Thromboxane Receptor Antagonists for Alzheimer's Disease Therapy
用于治疗阿尔茨海默病的脑渗透性血栓烷受体拮抗剂
- 批准号:
8042254 - 财政年份:2010
- 资助金额:
$ 31.15万 - 项目类别:
Brain-Penetrant Thromboxane Receptor Antagonists for Alzheimer's Disease Therapy
用于治疗阿尔茨海默病的脑渗透性血栓烷受体拮抗剂
- 批准号:
8149817 - 财政年份:2010
- 资助金额:
$ 31.15万 - 项目类别:
DEVELOPMENT OF DRUGS FOR SCHIZOPHRENIA AND DEMENTIA
精神分裂症和痴呆症药物的开发
- 批准号:
2537537 - 财政年份:1998
- 资助金额:
$ 31.15万 - 项目类别:
GLIAL B-AMYLOID PEPTIDE RECEPTORS IN ALZHEIMER'S DISEASE
阿尔茨海默病中的胶质 B 淀粉样肽受体
- 批准号:
3488131 - 财政年份:1993
- 资助金额:
$ 31.15万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 31.15万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 31.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 31.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 31.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 31.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 31.15万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 31.15万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 31.15万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 31.15万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 31.15万 - 项目类别:
Studentship














{{item.name}}会员




